news
FDA approves drug to prevent heart failure in type 2 diabetes patients
Farxiga, a treatment to reduce the risk of heart failure in patients with type 2 diabetes has been approved by the FDA.
List view / Grid view
Type 2 Diabetes
Filter the results
article
Top 10 drugs by annual revenue in 2025
Researchers have revealed the top 10 drugs by annual revenue in 2025. Here, we investigate the indications that necessitate these treatments and the delivery systems they employ.
news
EMA CHMP recommends seven medicines for approval
The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.
news
First oral GLP-1 treatment for type 2 diabetes approved
With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.
news
NHS releases guidance to remove drugs from prescription list
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
news
Type 2 diabetes treatment approved for children and adolescents
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
news
Application to EMA filed for the approval of oral semaglutide
It has been announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMA) for oral semaglutide.
news
Brilinta shows promise in phase III clinical trial
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
news
Canagliflozin may not be associated with fracture risk in diabetes patients
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...
news
Insulin supply chain transparency needed to prevent price hikes
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...
news
Lixisenatide prevents damage to kidneys in diabetes and CVD patients
Lixisenatide has shown prevention of kidney damage in patients with type 2 diabetes or cardiovascular disease through a study by the EASD...
news
Statins study questions their widespread use in the healthy elderly
A new observational study has identified no benefit from prescribing statins to healthy pensioners aged over 75 to prevent heart disease...
news
Collaboration to launch for the treatment of type 2 diabetes in China
Two companies will work closely together on future development, distribution, promotion, access, marketing and sales of Invokana (canagliflozin) for type 2 diabetes...
news
GDM points toward heightened risk of heart disease
Women who have gestational diabetes mellitus during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future...
news
Interactive app provides disease management tool for diabetes
Scientists have developed an online interactive app to help motivate patients to be more active in managing their disease...